In the second installment of this two-part series, Dr. Stacey Clardy and Dr. Janis Miyasaki discuss how she got involved with the AAN.

Show reference:

https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer examine the dichotomy that existed before his team began this project.

Show reference:

https://www.nature.com/articles/s41593-025-01910-9

In the first installment of this two-part series, Dr. Stacey Clardy engages in a thought-provoking conversation with Dr. Janis Miyasaki, asking her to share two invaluable pieces of wisdom.

Show reference:

https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award

Dr. Jeff Lambe talks about progressive multiple sclerosis.

Show references:

https://journals.lww.com/co-neurology/abstract/2025/06000/re_defining_progression_in_multiple_sclerosis.4.aspx

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00281-8/abstract

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70256-X/abstract

https://www.tandfonline.com/doi/full/10.1080/14737175.2022.2143265

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288967

https://jamanetwork.com/journals/jamaneurology/article-abstract/2809772

https://www.nejm.org/doi/full/10.1056/NEJMoa2415988

Dr. Justin Abbatemarco discuss autoimmune encephalitis with a focus on outcomes.

Show reference:

https://www.neurology.org/doi/10.1212/WNL.0000000000210109

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract

In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.

Dr. Jessica Ailani and Dr. Kathleen Digre discuss the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.

In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic.